Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Valens Semiconductor stock dips in premarket after 59% spike; VA7000 ADAS win still in focus

Valens Semiconductor stock dips in premarket after 59% spike; VA7000 ADAS win still in focus

New York, January 12, 2026, 05:49 EST — Premarket Valens Semiconductor Ltd shares dropped 4.4% to $2.37 in early Monday trading, pulling back from last week’s big surge. The stock finished Friday at $2.48, jumping 59% for the day after swinging between $1.63 and $2.72 on volume nearing 45 million shares. (StockAnalysis) The move stands out since Valens is a small, thinly traded chip stock, and the volume surge on Friday felt more like a shift in tone than a typical bounce. Investors are quick to react to any sign of broader adoption for new in-car sensor links, even if
Exxon stock moves premarket on Trump’s Venezuela warning — what to watch before the open

Exxon stock moves premarket on Trump’s Venezuela warning — what to watch before the open

New York, Jan 12, 2026, 05:53 EST — Premarket Exxon Mobil Corp shares climbed 1.4% to $124.61 in U.S. premarket Monday. President Donald Trump suggested he could block the oil giant from investing in Venezuela, following CEO Darren Woods’ description of the country as “uninvestable.” (Reuters) Washington’s push to revive Venezuelan oil exports and lure private investment into a sector crippled by sanctions and neglect is driving the headlines. For Exxon, a comeback would put its insistence on clear rules and strong safeguards to the test — adding a political edge to a stock that’s already sensitive to crude price
Hims & Hers Health (HIMS) stock slides premarket after Amazon’s Wegovy pill move — what traders watch next

Hims & Hers Health (HIMS) stock slides premarket after Amazon’s Wegovy pill move — what traders watch next

NEW YORK, Jan 12, 2026, 05:28 EST — Premarket Shares of Hims & Hers Health, Inc. slipped 2.2% in premarket trading Monday, hitting $31.00. The stock had already fallen 6.4% on Friday to $31.69 amid heavy volume. (StockAnalysis) The selloff late in the week came after Amazon Pharmacy began offering Novo Nordisk’s newly approved Wegovy weight-loss pill via insurance plans and a cash-pay option, opening yet another major channel in a market Hims has heavily relied on for growth. (Reuters) This is crucial now since investors see weight loss as Hims’ key growth driver: it attracts fresh users but can
Pan American Silver PAAS stock jumps in premarket as silver smashes records — what to watch next

Pan American Silver PAAS stock jumps in premarket as silver smashes records — what to watch next

New York, Jan 12, 2026, 05:30 EST — Premarket Pan American Silver Corp shares rose 4.5% in U.S. premarket trading on Monday, lifting the stock to $56.70 as precious metals ripped higher. (Public) Silver hit fresh records as investors rushed into “hard” assets after headlines around a criminal probe involving Federal Reserve Chair Jerome Powell and a sharper geopolitical backdrop. “With the Fed’s independence now openly contested,” investors were shifting toward hard assets, said Zain Vawda, an analyst at MarketPulse by OANDA. (Reuters) Silver futures were last up about 6% on CME’s Globex session early Monday. That matters for miners
Tempus AI stock jumps in premarket after $1.27 billion revenue preview, contract value tops $1.1 billion

Tempus AI stock jumps in premarket after $1.27 billion revenue preview, contract value tops $1.1 billion

New York, Jan 12, 2026, 05:29 EST — Premarket Tempus AI, Inc. shares were up about 11% in premarket trading on Monday after the company flagged strong preliminary 2025 results and reported record contract value with drugmakers. Tempus AI traded at $73.66 in premarket action, after ending Friday at $66.27. (google.com) The update lands as investors head into the annual J.P. Morgan Healthcare Conference week, when companies often try to reset expectations and pitch their 2026 story. Tempus has been a high-beta name in that mix, moving sharply on growth signals. For Tempus, the market focus has narrowed to two
Mereo BioPharma stock steadies premarket as JPM Healthcare Conference puts MREO back in play

Mereo BioPharma stock steadies premarket as JPM Healthcare Conference puts MREO back in play

New York, January 12, 2026, 05:24 EST — Premarket Mereo BioPharma Group plc shares held steady near $0.49 in U.S. premarket trading Monday, following a strong 28.6% jump to $0.4944 at Friday’s close. (The Wall Street Journal) Timing is key here. The J.P. Morgan Healthcare Conference is set for Jan. 12-15 in San Francisco, a week known for sharp moves in small biotech stocks on any news of partnerships, cost reductions, or strategic shifts. Last week, Mereo announced that CEO Denise Scots-Knight will present on Jan. 14. (JPMorgan Chase) Mereo has been struggling to bounce back since late December, when
NovaBay Pharmaceuticals (NBY) stock slides premarket after 102% surge — dilution risk back on radar

NovaBay Pharmaceuticals (NBY) stock slides premarket after 102% surge — dilution risk back on radar

New York, January 12, 2026, 05:15 EST — Premarket NovaBay Pharmaceuticals, Inc. shares slipped roughly 10% in early Monday trading, falling to $17.21 after finishing Friday at $19.16. This dip comes after a notable surge in the lightly traded stock on the NYSE American. https://stockanalysis.com/stocks/nby/ Friday’s surge was extreme, even for a microcap. Shares closed up 102.5%, swinging between $9.69 and $19.95, on roughly 10 million shares changing hands, according to StockAnalysis data. https://stockanalysis.com/stocks/nby/history/ This is crucial now, as the stock has morphed into a momentum play within just a few sessions. Such trades hinge heavily on share availability. With
Barclays stock slides on Trump’s 10% credit-card rate cap call as investors size up profit hit

Barclays stock slides on Trump’s 10% credit-card rate cap call as investors size up profit hit

London, January 12, 2026, 10:13 GMT — Regular session underway. Shares of Barclays (BARC.L) in London dropped 3.5% on Monday following U.S. President Donald Trump’s push to cap credit card interest rates at 10%. Barclays’ U.S. card business ranks ninth in that market, accounting for roughly 11% of the group’s profits, said Matt Britzman, senior equity analyst at Hargreaves Lansdown. (Reuters) The shift is significant as it pulls politics directly into consumer lending, a space known for high margins but also sudden regulatory shifts that can upend the numbers. For Barclays, U.S. credit cards have been a relatively straightforward growth
Abivax stock jumps on fresh Eli Lilly takeover talk as ABVX.PA hits record — what traders watch next

Abivax stock jumps on fresh Eli Lilly takeover talk as ABVX.PA hits record — what traders watch next

Paris, Jan 12, 2026, 11:17 CET — Regular session Shares in ABIVAX Société Anonyme surged Monday following a French media report that stirred new takeover speculation involving the biotech and U.S. pharmaceutical giant Eli Lilly. (Reuters) The stock climbed roughly 22% to 120.60 euros, hitting a peak of 130 euros earlier, based on Euronext-tracked quotes. It closed at 99 euros on Friday. (MarketScreener Canada) Why it matters now: Abivax is among the busiest biotech stocks in Paris at these levels, with even whispers of a deal sending its shares sharply higher. A one-day surge above 20% puts short-term funds on
IREN Limited stock (NASDAQ: IREN) nudges up premarket as bitcoin steadies and CPI looms

IREN Limited stock (NASDAQ: IREN) nudges up premarket as bitcoin steadies and CPI looms

New York, Jan 12, 2026, 04:51 EST — Premarket IREN Limited’s shares ticked up roughly 0.7% to $46.03 in early premarket action Monday. The stock finds itself caught between two fast-moving trades: crypto pricing and the surge in demand for power-hungry AI computing. Tuesday at 8:30 a.m. ET brings the U.S. consumer price index report for December, a key figure that frequently shakes up rates and risk assets. Bitcoin edged up 0.1%, hovering around $90,714. Crypto-mining stocks showed a mixed bag: Marathon Digital slipped nearly 2%, while Riot Platforms and Core Scientific gained 1.3% and 2.5%, respectively. CleanSpark dropped close
Oklo stock jumps again in premarket as Meta nuclear deal keeps OKLO in focus

Oklo stock jumps again in premarket as Meta nuclear deal keeps OKLO in focus

New York, Jan 12, 2026, 04:54 EST — Premarket Shares of Oklo Inc jumped roughly 7.9%, reaching $105.31 in early premarket action on Monday. The rally extends last week’s momentum, driven by renewed Big Tech interest in reliable power—a trend funneling capital into nuclear and its supply chain. Oklo’s appeal isn’t current output but the prospect of a long-term contract and a quicker route to funding. Meta Platforms announced on Friday it has sealed 20-year deals to buy power from three Vistra nuclear plants and will collaborate with Oklo and TerraPower on small modular reactors (SMRs)—smaller, more easily replicated reactors
Standard Chartered PLC stock slips after buyback update as green bond demand comes into focus

Standard Chartered PLC stock slips after buyback update as green bond demand comes into focus

London, Jan 12, 2026, 10:00 GMT — Regular session. Shares of Standard Chartered PLC slipped 0.1% to 1,793.5 pence in early London trade on Monday, following the bank’s announcement of additional share buybacks. The stock kicked off at 1,775.5 pence and moved between 1,763.0 and 1,793.5 pence. (lse.co.uk) The emerging-markets lender has pushed closer to its 52-week peak amid investor debate over capital returns versus funding expenses. Its shares have ranged from 872.8 pence to 1,875.5 pence in the last 12 months. Analysts tracked by Investing.com place the average price target near 1,669 pence. On the same day, NatWest and
1 330 331 332 333 334 884

Stock Market Today

Nvidia stock jumps nearly 8% as Big Tech AI spending bets lift chipmakers and Dow tops 50,000

Nvidia stock jumps nearly 8% as Big Tech AI spending bets lift chipmakers and Dow tops 50,000

7 February 2026
Nvidia surged 7.8% Friday, leading a chip stock rally that pushed the Dow above 50,000 for the first time. The PHLX semiconductor index gained 5.7% as Advanced Micro Devices rose 8.3% and Broadcom 7.1%. Amazon fell 5.6% after projecting $200 billion in 2026 capital spending. Investors weighed a $600 billion AI infrastructure outlay against sharp losses in software shares.
Glencore share price steadies after Rio Tinto walks away — what to watch next week

Glencore share price steadies after Rio Tinto walks away — what to watch next week

7 February 2026
Glencore shares closed up 0.6% at 478.1 pence Friday, rebounding after a 7% drop following the collapse of merger talks with Rio Tinto. The company is expected to announce the sale of its Kazzinc stake soon and has signed a non-binding agreement with Orion for a potential $9 billion deal in the DRC. Investors await Glencore’s full-year results on Feb. 18 for further guidance.
Go toTop